[A clinical study with prazosin].
D000317:Adrenergic alpha-Antagonists; D000328:Adult; D000368:Aged; D001581:Benzothiadiazines; D003863:Depression / Q000139:chemically induced; D004232:Diuretics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects*; D009126:Muscle Relaxation / Q000187:drug effects*; D011224:Prazosin / Q000009:adverse effects / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D012725:Sexual Behavior / Q000187:drug effects; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use; D014555:Urination Disorders / Q000139:chemically induced
D000317:Adrenergic alpha-Antagonists; D001581:Benzothiadiazines; D004232:Diuretics; D011799:Quinazolines; D049993:Sodium Chloride Symporter Inhibitors; D011224:Prazosin
Eine klinische Studie mit Prazosin.